1)DepoFoam多室脂质体
1.Preparation and characterization of pulmonary targeting DepoFoam loaded MR contrast media: gadopentetate dimeglumine;肺靶向性多室脂质体磁共振对比剂的制备及其特性分析
2)Unilamellar,single compartment liposome单室脂质体
3)multivesicular liposomes多囊脂质体
1.Preparation of tyroserlenutide multivesicular liposomes and drug release in vitro;酪丝亮肽多囊脂质体的制备和体外释放研究
2.Determination of entrapment efficiency of bulleyaconitine A multivesicular liposomes;草乌甲素多囊脂质体包封率的测定
英文短句/例句
1.Preparation and Technology Optimization of Aciclovir Multivesicular Liposomes阿昔洛韦多囊脂质体的制备工艺优选
2.Preparation and drug release in vitro of Thymopentin multivesicular liposomes胸腺五肽多囊脂质体的制备及体外释放的考察
3.Preparation and its release in vitro of multivesicular liposomes containing cytarabine阿糖胞苷多囊脂质体的制备及体外释放度考察
4.The Study of Complex Prescription Sulfamonomethoxine Sodium Multivesicular Liposome复方磺胺间甲氧嘧啶钠多囊脂质体的研制
5.Formulation and Preparation Technology of Multivesicular Liposomes Containing Oxymatrine氧化苦参碱多囊脂质体处方及制备工艺研究
6.Preliminary Study on Influence of Co-emulsifi ers on Multivesicular Liposomes助乳化剂对多囊脂质体影响的初步考察
7.Optimization of Preparation Technology and Property of Substance P Multivesicular LiposomesP物质多囊脂质体的制备工艺优化及相关性质考察
8.Study on Sustained-release Drug Delivery System of Protein Drugs Based on Multivesicular Liposomes Technology;基于多囊脂质体技术的蛋白质类药物缓释传递系统的研究
9.Preparation of ropivacaine hydrochloride multivesicular liposomes and release in vitro盐酸罗哌卡因多囊脂质体的制备及体外释放行为
10.Liposomes/niosomes for Vaginal Drug Delivery;脂质体/类脂泡囊阴道给药系统的研究
11.Preparation and characterization in vitro of levobupivacaine multivesicular liposome using multiple emulsion method复乳法制备左布比卡因多囊泡脂质体及其体外特性表征
12.Lateral Phase Separation and Budding in Multicomponent Lipid Vesicles;多组分脂质囊泡的侧向相分离与出芽
13.Preparation of Vitamin A Proliposomes and Research on Properties of Microencapsules维生素A前体脂质体的制备及微胶囊性质研究
14.Lipid Rafts and Caveolae are Essential for IGF-1 Receptor Signaling during 3T3-L1 Preadipocyte Differentiation Induction;脂质筏/质膜微囊在细胞膜受体信号转导中的作用
15.Insulin Resistance, Body Composition and Body Fat Distribution in Women with Polycystic Ovary Syndrome.;多囊卵巢综合征胰岛素抵抗与体成分、体脂分布相关性的研究
16.The Change of Mediator Levels in Liver Injured Mice Induced by LPS and Effects of Wuling Capsule脂多糖诱导小鼠肝损伤介质水平变化及五灵胶囊的作用
17.Chloroplast membranes form elongated flattened fluid-filled sacs called thylakoids.在叶绿体基质中,有许多由膜封闭形成的扁平小囊,称为类囊体。
18.Determination of zidovudine stearate content in its liposomes齐多夫定硬脂酸酯脂质体中药物含量的测定
相关短句/例句
Unilamellar,single compartment liposome单室脂质体
3)multivesicular liposomes多囊脂质体
1.Preparation of tyroserlenutide multivesicular liposomes and drug release in vitro;酪丝亮肽多囊脂质体的制备和体外释放研究
2.Determination of entrapment efficiency of bulleyaconitine A multivesicular liposomes;草乌甲素多囊脂质体包封率的测定
4)Polyphase liposme多相脂质体
5)Mmultivesicular liposomes多泡脂质体
6)Multivesicular liposome多囊脂质体
1.Aim To explore simple method to determine the interaction between peptide and lipid bilayer and then decide how to modify formulation from classic DepoFoam technology, multivesicular liposome of LXT-101(DepoLXT-101) was prepared as a modal, and resulting products were characterized by in vitro evaluation.目的采用物理测定方法探讨正电性合成多肽LXT-101与磷脂膜的相互作用并进行LXT-101多囊脂质体(DepoLXT-101)的处方工艺筛选,同时进行体外评价。
2.Using a simple method to determine the interaction between peptide and lipid bilayer and then deciding how to modify formulation from classic DepoFoam technology, multivesicular liposome of LXT-101 (DepoLXT-101) was prepared and characterized by in vitro evaluation.采用物理测定方法探讨正电性合成多肽LXT-101与磷脂膜的相互作用并进行LXT-101多囊脂质体(DepoLXT-101)的处方工艺筛选,同时进行体外评价。
3.The effects of L-lysine,polyvinyl alcohol and sodium alginate as co-emulsifier on the diameter and encapsulation effi ciency of the multivesicular liposomes were investigated.以拓扑替康为模型药物,采用复乳法制备多囊脂质体,考察了分别以L-赖氨酸、聚乙烯醇和海藻酸钠为助乳化剂对脂质体粒径和包封率的影响。
延伸阅读
脂质体分子式:分子量:CAS号:性质:一种水不溶性的、极性磷脂质组成的双层碟状液晶分子,在水中可形成一个或数个同心的脂质双分子层。脂质体可包蔽水和水溶性药物,也可将脂溶性药物结合在双分子层的脂质部分。脂质体在结构上可分为单层脂质体(直径约25纳米)、多层脂质体(约100纳米)和大脂质体(约0.13微米左右)。其特点是可减少剂量、降低毒性,减轻变态反应,可延缓药物的释放,减少药物在体内消除程度,提高药物的治疗效果,改变药物在组织中的分布,增强药物的选择性作用。